v3.26.1
Consolidated Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Beginning balance, value at Jun. 12, 2025 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Net income (loss) (597)     0 (597)  
Ending balance, value at Jun. 30, 2025 (597) $ 0 $ 0 0 (597) $ 0
Ending Balance, Shares at Jun. 30, 2025   0 0     0
Issuance of shares under Equity Facility, value $ 659,045   $ 761 658,284    
Issuance of shares under Equity Facility, share 20,463   76,063,600      
Exercise of warrants, shares 498,887   498,887      
Exercise of warrants, value     $ 5 (5)    
Issuance of shares to Board of Directors, in lieu of cash, shares     20,463      
Issuance of shares to Board of Directors, in lieu of cash $ 104     104    
Member cash contribution to Rorschach 750     750 0  
Equity issued related to acquisition of Sonnet, value 39,572 $ 0 $ 37 39,535 0 $ 0
Equity issued related to acquisition of Sonnet, shares   0 3,680,346     0
Closing PIPE financing, net of offering costs, value 878,043 $ 2 $ 1,233 876,808 0 $ 0
Closing PIPE financing, net of offering costs, shares   166,173 123,354,259     0
Acquisition of treasury stock, value (10,481) $ 0 $ 0 0 0 $ (10,481)
Acquisition of treasury stock, shares   0 (3,067,097)     3,067,097
Stock-based compensation,Value 893     893    
Net income (loss) 305,542       305,542  
Ending balance, value at Jun. 30, 2026 $ 1,872,871 $ 2 $ 2,036 $ 1,576,369 $ 304,945 $ (10,481)
Ending Balance, Shares at Jun. 30, 2026   166,173 200,550,458     3,067,097